{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:58:22Z","timestamp":1781769502309,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nutritional rickets, caused by vitamin D and\/or calcium deficiency is by far the most common cause of rickets. In resource-limited settings, it is therefore not uncommon to treat rickets with vitamin D and calcium. If rickets fails to heal and\/or if there is a family history of rickets, then refractory rickets should be considered as a differential diagnosis. Chronic low serum phosphate is the pathological hallmark of all forms of rickets as its low concentration in extracellular space leads to the failure of apoptosis of hypertrophic chondrocytes leading to defective mineralisation of the growth plate. Parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23) control serum phosphate concentration by facilitating the excretion of phosphate in the urine through their action on the proximal renal tubules. An increase in PTH, as seen in nutritional rickets and genetic disorders of vitamin D-dependent rickets (VDDRs), leads to chronic low serum phosphate, causing rickets. Genetic conditions leading to an increase in FGF23 concentration cause chronic low serum phosphate concentration and rickets. Genetic conditions and syndromes associated with proximal renal tubulopathies can also lead to chronic low serum phosphate concentration by excess phosphate leak in urine, causing rickets.<\/jats:p><jats:p>In this review, authors discuss an approach to the differential diagnosis and management of refractory rickets.<\/jats:p>","DOI":"10.1007\/s12098-023-04538-4","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T04:13:09Z","timestamp":1681877589000},"page":"574-581","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Refractory Rickets"],"prefix":"10.1007","volume":"90","author":[{"given":"Amish","family":"Chinoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3350-9896","authenticated-orcid":false,"given":"Raja","family":"Padidela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"key":"4538_CR1","doi-asserted-by":"publisher","first-page":"9637","DOI":"10.1073\/pnas.0502249102","volume":"102","author":"Y Sabbagh","year":"2005","unstructured":"Sabbagh Y, Carpenter TO, Demay MB. Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes. Proc Natl Acad Sci U S A. 2005;102:9637\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4538_CR2","doi-asserted-by":"publisher","DOI":"10.2174\/1573396319666221221121350","author":"NL Perumal","year":"2022","unstructured":"Perumal NL, Padidela R. Phosphate homeostasis and disorders of phosphate metabolism. Curr Pediatr Rev. 2022. https:\/\/doi.org\/10.2174\/1573396319666221221121350.","journal-title":"Curr Pediatr Rev"},{"key":"4538_CR3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13023-020-01434-4","volume":"15","author":"R Padidela","year":"2020","unstructured":"Padidela R, Nilsson O, Makitie O, et al. The international X-linked hypophosphataemia (XLH) registry (NCT03193476): rationale for and description of an international, observational study. Orphanet J Rare Dis. 2020;15:172.","journal-title":"Orphanet J Rare Dis"},{"key":"4538_CR4","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1093\/clinchem\/34.8.1622","volume":"34","author":"G Lockitch","year":"1988","unstructured":"Lockitch G, Halstead AC, Albersheim S, MacCallum C, Quigley G. Age- and sex-specific pediatric reference intervals for biochemistry analytes as measured with the Ektachem-700 analyzer. Clin Chem. 1988;34:1622\u20135.","journal-title":"Clin Chem"},{"key":"4538_CR5","doi-asserted-by":"publisher","first-page":"116025","DOI":"10.1016\/j.bone.2021.116025","volume":"151","author":"S Uday","year":"2021","unstructured":"Uday S, Shaw NJ, Mughal MZ, et al. Monitoring response to conventional treatment in children with XLH: value of ALP and Rickets Severity score (RSS) in a real world setting. Bone. 2021;151:116025.","journal-title":"Bone"},{"key":"4538_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1159\/000184216","volume":"44","author":"H Stark","year":"1986","unstructured":"Stark H, Eisenstein B, Tieder M, Rachmel A, Alpert G. Direct measurement of TP\/GFR: a simple and reliable parameter of renal phosphate handling. Nephron. 1986;44:125\u20138.","journal-title":"Nephron"},{"key":"4538_CR7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1177\/000456329803500203","volume":"35","author":"RB Payne","year":"1998","unstructured":"Payne RB. Renal tubular reabsorption of phosphate (TmP\/GFR): indications and interpretation. Ann Clin Biochem. 1998;35:201\u20136.","journal-title":"Ann Clin Biochem"},{"key":"4538_CR8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","volume":"15","author":"D Haffner","year":"2019","unstructured":"Haffner D, Emma F, Eastwood DM, et al. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia. Nat Rev Nephrol. 2019;15:435\u201355.","journal-title":"Nat Rev Nephrol"},{"key":"4538_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1046\/j.1365-2265.2003.01685.x","volume":"58","author":"O Makitie","year":"2003","unstructured":"Makitie O, Kooh SW, Sochett E. Prolonged high-dose phosphate treatment: a risk factor for tertiary hyperparathyroidism in X-linked hypophosphatemic rickets. Clin Endocrinol (Oxf). 2003;58:163\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4538_CR10","doi-asserted-by":"publisher","first-page":"658","DOI":"10.2215\/CJN.04981107","volume":"3","author":"US Alon","year":"2008","unstructured":"Alon US, Levy-Olomucki R, Moore WV, Stubbs J, Liu S, Quarles LD. Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets. Clin J Am Soc Nephrol. 2008;3:658\u201364.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4538_CR11","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1210\/jc.2009-1671","volume":"95","author":"EA Imel","year":"2010","unstructured":"Imel EA, DiMeglio LA, Hui SL, Carpenter TO, Econs MJ. Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations. J Clin Endocrinol Metab. 2010;95:1846\u201350.","journal-title":"J Clin Endocrinol Metab"},{"key":"4538_CR12","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","volume":"378","author":"TO Carpenter","year":"2018","unstructured":"Carpenter TO, Whyte MP, Imel EA, et al. Burosumab therapy in children with x-linked hypophosphatemia. N Engl J Med. 2018;378:1987\u201398.","journal-title":"N Engl J Med"},{"key":"4538_CR13","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1007\/s00223-020-00797-x","volume":"108","author":"R Padidela","year":"2021","unstructured":"Padidela R, Whyte MP, Glorieux FH, et al. Patient-reported outcomes from a randomized, active-controlled, open-label, phase 3 trial of burosumab versus conventional therapy in children with X-linked hypophosphatemia. Calcif Tissue Int. 2021;108:622\u201333.","journal-title":"Calcif Tissue Int"},{"key":"4538_CR14","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1530\/EC-20-0291","volume":"9","author":"R Padidela","year":"2020","unstructured":"Padidela R, Cheung MS, Saraff V, Dharmaraj P. Clinical guidelines for burosumab in the treatment of XLH in children and adolescents: british paediatric and adolescent bone group recommendations. Endocr Connect. 2020;9:1051\u20136.","journal-title":"Endocr Connect"},{"key":"4538_CR15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/jbmr.3941","volume":"35","author":"W Hogler","year":"2020","unstructured":"Hogler W, Kapelari K. Oral iron for prevention and treatment of rickets and osteomalacia in autosomal dominant hypophosphatemia. J Bone Miner Res. 2020;35:226\u201330.","journal-title":"J Bone Miner Res"},{"key":"4538_CR16","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1210\/jc.2003-030036","volume":"88","author":"O Makitie","year":"2003","unstructured":"Makitie O, Doria A, Kooh SW, Cole WG, Daneman A, Sochett E. Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab. 2003;88:3591\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"4538_CR17","doi-asserted-by":"publisher","first-page":"16790","DOI":"10.1038\/s41598-022-21279-0","volume":"12","author":"A Khadilkar","year":"2022","unstructured":"Khadilkar A, Kajale N, Oza C, et al. Vitamin D status and determinants in indian children and adolescents: a multicentre study. Sci Rep. 2022;12:16790.","journal-title":"Sci Rep"},{"key":"4538_CR18","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1124\/mol.111.076356","volume":"81","author":"Z Wang","year":"2012","unstructured":"Wang Z, Lin YS, Zheng XE, et al. An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway. Mol Pharmacol. 2012;81:498\u2013509.","journal-title":"Mol Pharmacol"},{"key":"4538_CR19","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s00223-020-00784-2","volume":"108","author":"SB Kaygusuz","year":"2021","unstructured":"Kaygusuz SB, Alavanda C, Kirkgoz T, et al. Does genotype-phenotype correlation exist in vitamin d-dependent rickets type IA: report of 13 new cases and review of the literature. Calcif Tissue Int. 2021;108:576\u201386.","journal-title":"Calcif Tissue Int"},{"key":"4538_CR20","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1515\/jpem-2021-0403","volume":"34","author":"MH Dodamani","year":"2021","unstructured":"Dodamani MH, Sehemby M, Memon SS, et al. Genotype and phenotypic spectrum of vitamin D dependent rickets type 1A: our experience and systematic review. J Pediatr Endocrinol Metab. 2021;34:1505\u201313.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"4538_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4274\/jcrpe.galenos.2018.2018.0121","volume":"11","author":"F Dursun","year":"2019","unstructured":"Dursun F, Ozgurhan G, Kirmizibekmez H, Keskin E, Hacihamdioglu B. Genetic and clinical characteristics of patients with vitamin d dependent rickets type 1A. J Clin Res Pediatr Endocrinol. 2019;11:34\u201340.","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"4538_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1210\/jc.2010-1340","volume":"96","author":"T Edouard","year":"2011","unstructured":"Edouard T, Alos N, Chabot G, Roughley P, Glorieux FH, Rauch F. Short- and long-term outcome of patients with pseudo-vitamin D deficiency rickets treated with calcitriol. J Clin Endocrinol Metab. 2011;96:82\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"4538_CR23","doi-asserted-by":"publisher","first-page":"E1005","DOI":"10.1210\/jc.2015-1746","volume":"100","author":"TD Thacher","year":"2015","unstructured":"Thacher TD, Fischer PR, Singh RJ, Roizen J, Levine MA. CYP2R1 mutations impair generation of 25-hydroxyvitamin d and cause an atypical form of vitamin D deficiency. J Clin Endocrinol Metab. 2015;100:E1005\u201313.","journal-title":"J Clin Endocrinol Metab"},{"key":"4538_CR24","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/jbmr.3181","volume":"32","author":"A Molin","year":"2017","unstructured":"Molin A, Wiedemann A, Demers N, et al. Vitamin D-dependent rickets type 1B (25-hydroxylase deficiency): a rare condition or a misdiagnosed condition? J Bone Miner Res. 2017;32:1893\u20139.","journal-title":"J Bone Miner Res"},{"key":"4538_CR25","first-page":"156","volume":"20","author":"PJ Malloy","year":"1999","unstructured":"Malloy PJ, Pike JW, Feldman D. The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr Rev. 1999;20:156\u201388.","journal-title":"Endocr Rev"},{"key":"4538_CR26","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/jcp.20578","volume":"207","author":"DD Bikle","year":"2006","unstructured":"Bikle DD, Elalieh H, Chang S, Xie Z, Sundberg JP. Development and progression of alopecia in the vitamin D receptor null mouse. J Cell Physiol. 2006;207:340\u201353.","journal-title":"J Cell Physiol"},{"key":"4538_CR27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1365-2265.1986.tb01703.x","volume":"25","author":"SJ Marx","year":"1986","unstructured":"Marx SJ, Bliziotes MM, Nanes M. Analysis of the relation between alopecia and resistance to 1,25-dihydroxyvitamin D. Clin Endocrinol (Oxf). 1986;25:373\u201381.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"4538_CR28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1515\/JPEM.2007.20.3.425","volume":"20","author":"P Nicolaidou","year":"2007","unstructured":"Nicolaidou P, Tsitsika A, Papadimitriou A, et al. Hereditary vitamin D-resistant rickets in greek children: genotype, phenotype, and long-term response to treatment. J Pediatr Endocrinol Metab. 2007;20:425\u201330.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"4538_CR29","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1210\/jc.2011-1432","volume":"96","author":"D Tiosano","year":"2011","unstructured":"Tiosano D, Hadad S, Chen Z, et al. Calcium absorption, kinetics, bone density, and bone structure in patients with hereditary vitamin D-resistant rickets. J Clin Endocrinol Metab. 2011;96:3701\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"4538_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1399-0004.1995.tb04056.x","volume":"48","author":"A Giraldo","year":"1995","unstructured":"Giraldo A, Pino W, Garcia-Ramirez LF, Pineda M, Iglesias A. Vitamin D dependent rickets type II and normal vitamin D receptor cDNA sequence. A cluster in a rural area of Cauca, Colombia, with more than 200 affected children. Clin Genet. 1995;48:57\u201365.","journal-title":"Clin Genet"},{"key":"4538_CR31","doi-asserted-by":"publisher","first-page":"39114","DOI":"10.1074\/jbc.M608006200","volume":"281","author":"H Chen","year":"2006","unstructured":"Chen H, Hewison M, Adams JS. Functional characterization of heterogeneous nuclear ribonuclear protein C1\/C2 in vitamin D resistance: a novel response element-binding protein. J Biol Chem. 2006;281:39114\u201320.","journal-title":"J Biol Chem"},{"key":"4538_CR32","doi-asserted-by":"publisher","first-page":"6109","DOI":"10.1073\/pnas.1031395100","volume":"100","author":"H Chen","year":"2003","unstructured":"Chen H, Hewison M, Hu B, Adams JS. Heterogeneous nuclear ribonucleoprotein (hnRNP) binding to hormone response elements: a cause of vitamin D resistance. Proc Natl Acad Sci U S A. 2003;100:6109\u201314.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4538_CR33","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1172\/JCI98680","volume":"128","author":"JD Roizen","year":"2018","unstructured":"Roizen JD, Li D, O\u2019Lear L, et al. CYP3A4 mutation causes vitamin D-dependent rickets type 3. J Clin Invest. 2018;128:1913\u20138.","journal-title":"J Clin Invest"},{"key":"4538_CR34","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/jbmr.1839","volume":"28","author":"Z Wang","year":"2013","unstructured":"Wang Z, Lin YS, Dickmann LJ, et al. Enhancement of hepatic 4-hydroxylation of 25-hydroxyvitamin D3 through CYP3A4 induction in vitro and in vivo: implications for drug-induced osteomalacia. J Bone Miner Res. 2013;28:1101\u201316.","journal-title":"J Bone Miner Res"},{"key":"4538_CR35","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3389\/fped.2018.00376","volume":"6","author":"RC Nicolescu","year":"2018","unstructured":"Nicolescu RC, Lombet J, Cavalier E. Vitamin D-resistant rickets and cinacalcet-one more favorable experience. Front Pediatr. 2018;6:376.","journal-title":"Front Pediatr"}],"container-title":["Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-023-04538-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-023-04538-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-023-04538-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T02:36:03Z","timestamp":1685068563000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-023-04538-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["4538"],"URL":"https:\/\/doi.org\/10.1007\/s12098-023-04538-4","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,19]]},"assertion":[{"value":"5 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RP has received a research grant and honorarium for participating in scientific meetings from Kyowa Kirin International, UK.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}